Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion

Gilead Sciences has agreed to bargain the remainder of improvement spouse Arcellx successful a woody that values the biotechnology institution astatine astir $7.8 cardinal astatine closing.